Biogen Inc. (NASDAQ:BIIB) Biogen and Sage Zuranolone Webcast December 6, 2022 8:00 AM ET Company Participants Helen Rubinstein - Director, Investor Relations, Sage Therapeutics Chris Benecchi - Chief Business Officer, Sage Therapeutics Maha Radhakrishnan - Group SVP and Chief Medical Officer, Biogen Greg Mattingly - Associate Clinical Professor, Washington University Alisha Alaimo - President of U.S. Organization, Biogen Mike Hencke - Head, Investor Relations, Biogen Jim Doherty - Chief Development Officer, ...

Biogen Inc. (NASDAQ:BIIB) 5th Annual Evercore ISI HealthCONx Conference Call December 1, 2022 10:30 AM ET Company Participants Mike McDonnell - Chief Financial Officer Priya Singhal - Head of Global Safety and Regulatory Sciences and Interim Head of R&D Conference Call Participants Umer Raffat - Evercore ISI Umer Raffat Hello, everyone. Pleasure to have Biogen management join us right after Merck and there’s a lot to talk about, but let me turn it over to you, Mike, to kick things off. Mike McDonnell Excell ...

Biogen Inc. (NASDAQ:BIIB) Q3 2022 Earnings Conference Call October 25, 2022 8:00 AM ET Company Participants Mike Hencke - Head, Investor Relations Michel Vounatsos - Chief Executive Officer Priya Singhal - Interim Head, Research & Development Michael McDonnell - Chief Financial Officer Conference Call Participants Umer Raffat - Evercore Brian Abrahams - RBC Capital Markets Salveen Richter - Goldman Sachs Tim Anderson - Wolfe Research Chris Raymond - Piper Sandler Matthew Harrison - Morgan Stanley Brian Skor ...

Biogen Inc. (NASDAQ:BIIB) Morgan Stanley 20th Annual Global Healthcare Conference Call September 12, 2022 9:55 AM ET Company Participants Michael McDonnell - Chief Financial Officer Priya Singhal - Head of Global Safety and Regulatory Sciences and Interim Head of R&D Conference Call Participants Matthew Harrison - Morgan Stanley & Co. LLC Matthew Harrison Great. Good morning, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Real ...

Biogen Inc. (NASDAQ:BIIB) Q2 2022 Earnings Conference Call July 20, 2022 8:00 AM ET Company Participants Michael Hencke - Head of IR Michel Vounatsos - CEO Priya Singhal - Interim Head, Research and Development Michael McDonnell - CFO Conference Call Participants Brian Abrahams - RBC Capital Markets Matthew Harrison - Morgan Stanley Colin Bristow - UBS Michael Yee - Jefferies Umer Raffat - Evercore ISI Marc Goodman - SVB Securities Salveen Richter - Goldman Sachs Robyn Karnauskas - Truist Securities Cory Ka ...